Nephros, Inc.
NEPH
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $44.1M
$4.06
▼ -2.87%
P/E
25.26
Mkt Cap
$44.1M
52-Wk Range
$2.66–$6.42
52-Week Range
$2.66 - $6.42
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 3.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary ultrafiltration and water purification technology
- FDA-cleared medical devices with regulatory moats
- Diversified customer base across medical, commercial, and military sectors
- Specialized expertise in waterborne pathogen prevention and detection
Bear Case
2 risks
- Above-average volatility (beta 1.6).
- Premium valuation to sector peers
Growth
Stable outlook
Rising prevalence of end-stage renal disease and dialysis demand
Value
Premium valuation to sector peers
Momentum
Strong
+18.7% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying NEPH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $0.06 vs $0.00 consensus (+1701.8% surprise). Revenue of $6.0M vs $5.0M expected (+20.5%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+1701.8%
Revenue trend · last 6Q
—
+36%
+35%
+22%
+7%
+36%
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$4.9M
$4.4M
$4.8M
$4.7M
$5.2M
$6.0M
Margins · last 6Q
Gross
66.4%
Operating
20.2%
Profit
19.9%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How NEPH stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.